Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Farmers Insurance
AstraZeneca
Julphar
Federal Trade Commission
Merck
Moodys
Dow
Medtronic
Covington

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,990,176

« Back to Dashboard

Which drugs does patent 5,990,176 protect, and when does it expire?

Patent 5,990,176 protects ULTANE and is included in one NDA.

Protection for ULTANE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has fifty patent family members in twenty-seven countries.
Summary for Patent: 5,990,176
Title: Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
Abstract:The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
Inventor(s): Bieniarz; Christopher (Highland Park, IL), Chang; Steve H. (Gurnee, IL), Cromack; Keith R. (Lake Bluff, IL), Huang; Shuyen L. (Riverwoods, IL), Kawai; Toshikazu (Tsurugashima, JP), Kobayashi; Manami (Miyoshimachi, JP), Loffredo; David (Elmhurst, IL), Raghavan; Rajagopalan (Grayslake, IL), Speicher; Earl R. (Buffalo Grove, IL), Stelmach; Honorate A. (Lake Forest, IL)
Assignee: Abbott Laboratories (Abbott Park, IL) Central Glass Company Ltd. (Tokyo, JP)
Application Number:08/789,679
Patent Claim Types:
see list of patent claims
Composition; Use;

Drugs Protected by US Patent 5,990,176

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 AN RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 5,990,176

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,288,127 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid ➤ Subscribe
6,444,859 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid ➤ Subscribe
6,677,492 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,990,176

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 011090 ➤ Subscribe
Argentina 057610 ➤ Subscribe
Austria 201987 ➤ Subscribe
Austria 320798 ➤ Subscribe
Australia 5930098 ➤ Subscribe
Australia 726733 ➤ Subscribe
Bulgaria 103656 ➤ Subscribe
Bulgaria 109751 ➤ Subscribe
Bulgaria 65414 ➤ Subscribe
Brazil 9806996 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Deloitte
Accenture
Moodys
Cerilliant
Healthtrust
US Army
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot